Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 26 entries
View as:

A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00648674 Org: User:
Start: 07/31/08 End: 03/31/10 Due: 03/31/11

Prospective PuraPly™ AM Case Series Study

Phase: N/A Priority: Normal
NCT ID: NCT03070925 Org: User:
Start: 11/30/16 End: 05/31/17 Due: 05/31/18

Study of Nucel for One and Two Level Lumbar Interbody Fusion

Phase: N/A Priority: Normal
NCT ID: NCT02808234 Org: User:
Start: 12/31/15 End: 12/31/22 Due: 12/31/23

Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT03855514 Org: User:
Start: 02/08/19 End: 12/30/21 Due: 12/30/22

Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT01181440 Org: User:
Start: 09/30/94 End: 01/31/97 Due: 01/31/98

Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT02880592 Org: User:
Start: 08/31/16 End: 04/01/19 Due: 04/01/20

Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration

Phase: N/A Priority: Normal
NCT ID: NCT00587834 Org: User:
Start: 10/31/07 End: 12/31/08 Due: 12/31/09

A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva

Phase: N/A Priority: Normal
NCT ID: NCT01547962 Org: User:
Start: 09/30/05 End: 05/31/06 Due: 05/31/07

A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids

Phase: N/A Priority: Normal
NCT ID: NCT00587587 Org: User:
Start: 12/31/07 End: 03/31/10 Due: 03/31/11

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Phase: N/A Priority: Normal
NCT ID: NCT00587223 Org: User:
Start: 12/31/07 End: 12/31/08 Due: 12/31/09

Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT01181453 Org: User:
Start: 12/31/98 End: 03/31/00 Due: 03/31/01

Affinity Prospective Diabetic Foot Trial Crossover Group

Phase: N/A Priority: Normal
NCT ID: NCT03205436 Org: User:
Start: 05/01/17 End: 08/15/19 Due: 08/15/20

Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00512538 Org: User:
Start: 10/31/00 End: 09/30/02 Due: 09/30/03

A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT01327937 Org: User:
Start: 03/31/11 End: 12/31/13 Due: 12/31/14

Safety Study of Gintuit™ in Subjects Requiring Socket Grafting

Phase: N/A Priority: Normal
NCT ID: NCT01929954 Org: User:
Start: 07/31/13 End: 03/31/15 Due: 03/31/16

PuraPly™ Antimicrobial Wound Matrix and Wound Management

Phase: N/A Priority: Normal
NCT ID: NCT03070938 Org: User:
Start: 11/30/16 End: 10/31/17 Due: 10/31/18

A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®

Phase: N/A Priority: Normal
NCT ID: NCT02011724 Org: User:
Start: 11/30/13 End: 01/31/14 Due: 01/31/15

Clinical Study Of Affinity Versus SOC In The Management Of VLUs

Phase: N/A Priority: Normal
NCT ID: NCT04901013 Org: User:
Start: 06/14/21 End: 06/30/23 Due: 06/30/24

A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage

Phase: N/A Priority: Normal
NCT ID: NCT00679081 Org: User:
Start: 05/31/08 End: 09/30/10 Due: 09/30/11

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Phase: N/A Priority: Normal
NCT ID: NCT01292122 Org: User:
Start: 06/30/11 End: 09/30/12 Due: 09/30/13

A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients with Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT06000410 Org: User:
Start: 09/06/23 End: 03/31/26 Due: 03/31/27

Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT04636229 Org: User:
Start: 12/14/20 End: 06/30/25 Due: 06/30/26

The RESPOND Registry

Phase: N/A Priority: Normal
NCT ID: NCT03286452 Org: User:
Start: 02/21/17 End: 01/26/19 Due: 01/26/20

Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00909870 Org: User:
Start: 06/30/09 End: 08/31/11 Due: 08/31/12

PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.

Phase: N/A Priority: Normal
NCT ID: NCT03502824 Org: User:
Start: 05/01/18 End: 09/15/21 Due: 09/15/22